ZALANDO SE (ZAL.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:ZAL • DE000ZAL1111

21.41 EUR
+0.12 (+0.56%)
Last: Feb 9, 2026, 05:35 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Overall ZAL gets a fundamental rating of 5 out of 10. We evaluated ZAL against 59 industry peers in the Specialty Retail industry. Both the profitability and the financial health of ZAL get a neutral evaluation. Nothing too spectacular is happening here. ZAL is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, ZAL could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • ZAL had positive earnings in the past year.
  • In the past year ZAL had a positive cash flow from operations.
  • Each year in the past 5 years ZAL has been profitable.
  • In the past 5 years ZAL always reported a positive cash flow from operatings.
ZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • ZAL's Return On Assets of 2.66% is in line compared to the rest of the industry. ZAL outperforms 57.63% of its industry peers.
  • ZAL has a Return On Equity of 8.44%. This is in the better half of the industry: ZAL outperforms 66.10% of its industry peers.
  • ZAL's Return On Invested Capital of 5.47% is in line compared to the rest of the industry. ZAL outperforms 59.32% of its industry peers.
  • ZAL had an Average Return On Invested Capital over the past 3 years of 3.34%. This is significantly below the industry average of 9.72%.
  • The 3 year average ROIC (3.34%) for ZAL is below the current ROIC(5.47%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.66%
ROE 8.44%
ROIC 5.47%
ROA(3y)1.48%
ROA(5y)2.26%
ROE(3y)4.56%
ROE(5y)6.95%
ROIC(3y)3.34%
ROIC(5y)4.59%
ZAL.DE Yearly ROA, ROE, ROICZAL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.06%, ZAL is in the better half of the industry, outperforming 61.02% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ZAL has grown nicely.
  • With a Operating Margin value of 3.30%, ZAL perfoms like the industry average, outperforming 54.24% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ZAL has grown nicely.
  • ZAL's Gross Margin of 40.37% is fine compared to the rest of the industry. ZAL outperforms 62.71% of its industry peers.
  • In the last couple of years the Gross Margin of ZAL has remained more or less at the same level.
Industry RankSector Rank
OM 3.3%
PM (TTM) 2.06%
GM 40.37%
OM growth 3Y-2.26%
OM growth 5Y7.72%
PM growth 3Y1.6%
PM growth 5Y9.08%
GM growth 3Y-0.88%
GM growth 5Y-0.89%
ZAL.DE Yearly Profit, Operating, Gross MarginsZAL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ZAL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ZAL has been reduced compared to 1 year ago.
  • ZAL has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ZAL has an improved debt to assets ratio.
ZAL.DE Yearly Shares OutstandingZAL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
ZAL.DE Yearly Total Debt VS Total AssetsZAL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 2.23 indicates that ZAL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ZAL (2.23) is comparable to the rest of the industry.
  • The Debt to FCF ratio of ZAL is 3.63, which is a good value as it means it would take ZAL, 3.63 years of fcf income to pay off all of its debts.
  • ZAL's Debt to FCF ratio of 3.63 is fine compared to the rest of the industry. ZAL outperforms 69.49% of its industry peers.
  • ZAL has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
  • ZAL has a Debt to Equity ratio of 0.44. This is in the better half of the industry: ZAL outperforms 66.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.63
Altman-Z 2.23
ROIC/WACC0.88
WACC6.24%
ZAL.DE Yearly LT Debt VS Equity VS FCFZAL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 1.12 indicates that ZAL should not have too much problems paying its short term obligations.
  • ZAL has a Current ratio of 1.12. This is comparable to the rest of the industry: ZAL outperforms 42.37% of its industry peers.
  • ZAL has a Quick Ratio of 1.12. This is a bad value and indicates that ZAL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZAL's Quick ratio of 0.59 is in line compared to the rest of the industry. ZAL outperforms 54.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.59
ZAL.DE Yearly Current Assets VS Current LiabilitesZAL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • ZAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.72%, which is quite good.
  • The Earnings Per Share has been growing by 23.33% on average over the past years. This is a very strong growth
  • ZAL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.06%.
  • The Revenue has been growing by 10.28% on average over the past years. This is quite good.
EPS 1Y (TTM)17.72%
EPS 3Y2.91%
EPS 5Y23.33%
EPS Q2Q%-64.71%
Revenue 1Y (TTM)12.06%
Revenue growth 3Y0.7%
Revenue growth 5Y10.28%
Sales Q2Q%26.46%

3.2 Future

  • Based on estimates for the next years, ZAL will show a very strong growth in Earnings Per Share. The EPS will grow by 26.63% on average per year.
  • The Revenue is expected to grow by 10.27% on average over the next years. This is quite good.
EPS Next Y19.08%
EPS Next 2Y24.54%
EPS Next 3Y25.18%
EPS Next 5Y26.63%
Revenue Next Year16.7%
Revenue Next 2Y15.08%
Revenue Next 3Y11.96%
Revenue Next 5Y10.27%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ZAL.DE Yearly Revenue VS EstimatesZAL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
ZAL.DE Yearly EPS VS EstimatesZAL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 23.02, ZAL is valued on the expensive side.
  • 69.49% of the companies in the same industry are more expensive than ZAL, based on the Price/Earnings ratio.
  • ZAL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 14.23, the valuation of ZAL can be described as correct.
  • ZAL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ZAL is cheaper than 67.80% of the companies in the same industry.
  • ZAL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.02
Fwd PE 14.23
ZAL.DE Price Earnings VS Forward Price EarningsZAL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ZAL is valued a bit cheaper than 66.10% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZAL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 14.24
EV/EBITDA 7.18
ZAL.DE Per share dataZAL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • ZAL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of ZAL may justify a higher PE ratio.
  • A more expensive valuation may be justified as ZAL's earnings are expected to grow with 25.18% in the coming years.
PEG (NY)1.21
PEG (5Y)0.99
EPS Next 2Y24.54%
EPS Next 3Y25.18%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ZAL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZALANDO SE

FRA:ZAL (2/9/2026, 5:35:30 PM)

21.41

+0.12 (+0.56%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners60.67%
Inst Owner ChangeN/A
Ins Owners10.12%
Ins Owner ChangeN/A
Market Cap5.66B
Revenue(TTM)11.57B
Net Income(TTM)239.00M
Analysts78.18
Price Target36.87 (72.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.59%
Min EPS beat(2)-62.87%
Max EPS beat(2)-2.31%
EPS beat(4)2
Avg EPS beat(4)210.92%
Min EPS beat(4)-62.87%
Max EPS beat(4)892.08%
EPS beat(8)4
Avg EPS beat(8)93.43%
EPS beat(12)6
Avg EPS beat(12)41.34%
EPS beat(16)7
Avg EPS beat(16)-15.84%
Revenue beat(2)1
Avg Revenue beat(2)1.48%
Min Revenue beat(2)-0.03%
Max Revenue beat(2)2.99%
Revenue beat(4)3
Avg Revenue beat(4)1.29%
Min Revenue beat(4)-0.03%
Max Revenue beat(4)2.99%
Revenue beat(8)4
Avg Revenue beat(8)0.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.24%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)1.06%
PT rev (3m)0.06%
EPS NQ rev (1m)8.06%
EPS NQ rev (3m)16.18%
EPS NY rev (1m)-1.26%
EPS NY rev (3m)-2.96%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.86%
Valuation
Industry RankSector Rank
PE 23.02
Fwd PE 14.23
P/S 0.49
P/FCF 14.24
P/OCF 9.26
P/B 2
P/tB 4.61
EV/EBITDA 7.18
EPS(TTM)0.93
EY4.34%
EPS(NY)1.5
Fwd EY7.03%
FCF(TTM)1.5
FCFY7.02%
OCF(TTM)2.31
OCFY10.8%
SpS43.81
BVpS10.72
TBVpS4.65
PEG (NY)1.21
PEG (5Y)0.99
Graham Number14.98
Profitability
Industry RankSector Rank
ROA 2.66%
ROE 8.44%
ROCE 8.93%
ROIC 5.47%
ROICexc 8.23%
ROICexgc 18.89%
OM 3.3%
PM (TTM) 2.06%
GM 40.37%
FCFM 3.43%
ROA(3y)1.48%
ROA(5y)2.26%
ROE(3y)4.56%
ROE(5y)6.95%
ROIC(3y)3.34%
ROIC(5y)4.59%
ROICexc(3y)9.52%
ROICexc(5y)14.27%
ROICexgc(3y)13.4%
ROICexgc(5y)19.23%
ROCE(3y)5.45%
ROCE(5y)7.5%
ROICexgc growth 3Y8.96%
ROICexgc growth 5Y22.36%
ROICexc growth 3Y2.72%
ROICexc growth 5Y17.49%
OM growth 3Y-2.26%
OM growth 5Y7.72%
PM growth 3Y1.6%
PM growth 5Y9.08%
GM growth 3Y-0.88%
GM growth 5Y-0.89%
F-Score7
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.63
Debt/EBITDA 1.61
Cap/Depr 55.55%
Cap/Sales 1.85%
Interest Coverage 250
Cash Conversion 79.63%
Profit Quality 166.19%
Current Ratio 1.12
Quick Ratio 0.59
Altman-Z 2.23
F-Score7
WACC6.24%
ROIC/WACC0.88
Cap/Depr(3y)86.74%
Cap/Depr(5y)104.05%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.86%
Profit Quality(3y)549.88%
Profit Quality(5y)378.62%
High Growth Momentum
Growth
EPS 1Y (TTM)17.72%
EPS 3Y2.91%
EPS 5Y23.33%
EPS Q2Q%-64.71%
EPS Next Y19.08%
EPS Next 2Y24.54%
EPS Next 3Y25.18%
EPS Next 5Y26.63%
Revenue 1Y (TTM)12.06%
Revenue growth 3Y0.7%
Revenue growth 5Y10.28%
Sales Q2Q%26.46%
Revenue Next Year16.7%
Revenue Next 2Y15.08%
Revenue Next 3Y11.96%
Revenue Next 5Y10.27%
EBIT growth 1Y2.33%
EBIT growth 3Y-1.58%
EBIT growth 5Y18.79%
EBIT Next Year118.78%
EBIT Next 3Y43.23%
EBIT Next 5Y33.35%
FCF growth 1Y-18.24%
FCF growth 3Y16.44%
FCF growth 5Y84.9%
OCF growth 1Y-20.35%
OCF growth 3Y2.01%
OCF growth 5Y14.86%

ZALANDO SE / ZAL.DE FAQ

Can you provide the ChartMill fundamental rating for ZALANDO SE?

ChartMill assigns a fundamental rating of 5 / 10 to ZAL.DE.


Can you provide the valuation status for ZALANDO SE?

ChartMill assigns a valuation rating of 5 / 10 to ZALANDO SE (ZAL.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for ZALANDO SE?

ZALANDO SE (ZAL.DE) has a profitability rating of 6 / 10.


What is the valuation of ZALANDO SE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ZALANDO SE (ZAL.DE) is 23.02 and the Price/Book (PB) ratio is 2.


What is the financial health of ZALANDO SE (ZAL.DE) stock?

The financial health rating of ZALANDO SE (ZAL.DE) is 5 / 10.